Role of the ACB
The Advisory Committee on Biologicals (ACB) was formed in January 2012 to provide independent medical and scientific advice to the Minister for Health and the Therapeutic Goods Administration (TGA) in relation to the safety and efficacy of biological products ("biologicals").
The Committee is established under Regulation 39C of the Therapeutic Goods Regulations 1990. Members are appointed by the Minister.
Membership comprises of professionals with specific scientific, medical or clinical expertise, as well as appropriate consumer health issues relating to cell and tissue products.
Membership
The current membership of the committee can be found on our ACB members page.
2024 ACB proposed meeting dates
Meeting no. | Meeting dates |
|---|---|
ACB 19 | 24 May 2024 |
ACB 20 | 6 September 2024 |
ACB 21 | 8 November 2024 |
Contact details for the ACB
| ACB enquiries | Committee support enquiries | |
|---|---|---|
| acb@health.gov.au bloodandtissues@health.gov.au | Committees@health.gov.au | |
| Phone | 1800 678 799 | |
| Postal Address | Advisory Committee on Biologicals Therapeutic Goods Administration PO Box 100 WODEN ACT 2606 Attn: Scientific Evaluation Branch, MDP 122 | Committee Support Unit Therapeutic Goods Administration PO Box 100 WODEN ACT 2606 Attn: Collaboration Services Section, MDP 122 |
Outcomes
-
Meeting statementsAdvisory Committee on Biologicals meeting statement
-
Meeting statementsAdvisory Committee on Biologicals meeting statement
-
Meeting statementsAdvisory Committee on Biologicals meeting statement